Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 6 | 2024 | 153 | 1.570 |
Why?
|
| Embryo Implantation | 3 | 2024 | 218 | 1.430 |
Why?
|
| Fertility Preservation | 4 | 2021 | 61 | 1.250 |
Why?
|
| Embryo Transfer | 4 | 2023 | 48 | 1.000 |
Why?
|
| Infertility, Female | 4 | 2024 | 145 | 0.890 |
Why?
|
| Reproductive Techniques, Assisted | 4 | 2021 | 81 | 0.830 |
Why?
|
| Endometrium | 2 | 2024 | 287 | 0.820 |
Why?
|
| Cryopreservation | 3 | 2021 | 78 | 0.820 |
Why?
|
| Observational Studies as Topic | 1 | 2024 | 103 | 0.810 |
Why?
|
| Ovulation Induction | 1 | 2021 | 38 | 0.670 |
Why?
|
| Preimplantation Diagnosis | 1 | 2020 | 29 | 0.620 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 157 | 0.610 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 191 | 0.610 |
Why?
|
| Embryonic Development | 1 | 2020 | 200 | 0.570 |
Why?
|
| Ovary | 2 | 2021 | 345 | 0.560 |
Why?
|
| Oocytes | 1 | 2020 | 283 | 0.560 |
Why?
|
| Ovariectomy | 1 | 2018 | 152 | 0.530 |
Why?
|
| Anemia, Aplastic | 1 | 2018 | 60 | 0.530 |
Why?
|
| Pregnancy | 15 | 2024 | 7463 | 0.530 |
Why?
|
| Peritoneum | 1 | 2017 | 34 | 0.510 |
Why?
|
| Therapies, Investigational | 1 | 2016 | 13 | 0.500 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 615 | 0.490 |
Why?
|
| Uterus | 3 | 2017 | 540 | 0.480 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 125 | 0.480 |
Why?
|
| Infertility | 1 | 2017 | 75 | 0.470 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 79 | 0.470 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 611 | 0.460 |
Why?
|
| Fertility | 1 | 2017 | 260 | 0.430 |
Why?
|
| Genetic Testing | 1 | 2020 | 1105 | 0.390 |
Why?
|
| Laparoscopy | 1 | 2017 | 537 | 0.340 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 511 | 0.340 |
Why?
|
| Placenta Previa | 2 | 2021 | 66 | 0.320 |
Why?
|
| Female | 24 | 2024 | 70516 | 0.290 |
Why?
|
| Placenta Accreta | 2 | 2021 | 173 | 0.270 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 618 | 0.250 |
Why?
|
| Pregnancy Rate | 2 | 2023 | 39 | 0.240 |
Why?
|
| Neoplasms | 2 | 2018 | 2985 | 0.230 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2022 | 503 | 0.230 |
Why?
|
| Humans | 23 | 2024 | 130459 | 0.200 |
Why?
|
| Review Literature as Topic | 1 | 2024 | 55 | 0.200 |
Why?
|
| Treatment Failure | 1 | 2024 | 348 | 0.190 |
Why?
|
| Fibromyalgia | 1 | 2022 | 19 | 0.190 |
Why?
|
| Retrospective Studies | 7 | 2023 | 17619 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 169 | 0.180 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 81 | 0.180 |
Why?
|
| Adult | 9 | 2021 | 31103 | 0.170 |
Why?
|
| Fertilization | 1 | 2021 | 44 | 0.170 |
Why?
|
| Superovulation | 1 | 2020 | 11 | 0.170 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 19 | 0.160 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 53 | 0.160 |
Why?
|
| Blastocyst | 1 | 2020 | 73 | 0.160 |
Why?
|
| Maternal Age | 2 | 2017 | 136 | 0.160 |
Why?
|
| Research Design | 1 | 2024 | 714 | 0.150 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 116 | 0.150 |
Why?
|
| Maternal Mortality | 1 | 2020 | 78 | 0.150 |
Why?
|
| Aneuploidy | 1 | 2020 | 136 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 352 | 0.140 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2017 | 24 | 0.120 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 31 | 0.120 |
Why?
|
| Mullerian Ducts | 1 | 2017 | 43 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 506 | 0.120 |
Why?
|
| Cesarean Section | 1 | 2020 | 426 | 0.120 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 43 | 0.120 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2016 | 69 | 0.120 |
Why?
|
| Contraceptive Agents, Female | 1 | 2016 | 31 | 0.120 |
Why?
|
| Aromatase Inhibitors | 1 | 2016 | 78 | 0.110 |
Why?
|
| Leiomyoma | 1 | 2016 | 71 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2016 | 140 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 349 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2021 | 707 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 100 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2016 | 125 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2017 | 169 | 0.110 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 66 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2020 | 1075 | 0.100 |
Why?
|
| Androgens | 1 | 2016 | 245 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 787 | 0.100 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 80 | 0.100 |
Why?
|
| Germ Cells | 1 | 2014 | 201 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2021 | 8623 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 326 | 0.100 |
Why?
|
| Premature Birth | 1 | 2017 | 422 | 0.090 |
Why?
|
| Patient Selection | 1 | 2016 | 724 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2016 | 564 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1122 | 0.090 |
Why?
|
| Young Adult | 4 | 2020 | 10034 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 708 | 0.080 |
Why?
|
| Tissue Survival | 2 | 2021 | 7 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1879 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 28393 | 0.060 |
Why?
|
| Animals | 3 | 2021 | 33709 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 12838 | 0.050 |
Why?
|
| Pandemics | 2 | 2022 | 1115 | 0.050 |
Why?
|
| United States | 2 | 2017 | 11994 | 0.050 |
Why?
|
| Mice | 1 | 2020 | 18185 | 0.050 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 5 | 0.050 |
Why?
|
| Live Birth | 1 | 2022 | 73 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 5048 | 0.040 |
Why?
|
| Fibrin | 1 | 2022 | 64 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 20875 | 0.040 |
Why?
|
| Intention | 1 | 2021 | 103 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2022 | 201 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3809 | 0.040 |
Why?
|
| Sheep | 1 | 2021 | 220 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 254 | 0.040 |
Why?
|
| Iran | 1 | 2020 | 93 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 320 | 0.030 |
Why?
|
| Incidence | 2 | 2017 | 3338 | 0.030 |
Why?
|
| Placenta | 1 | 2022 | 500 | 0.030 |
Why?
|
| Child | 1 | 2018 | 26243 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1207 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 273 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 542 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1376 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 171 | 0.030 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 24 | 0.030 |
Why?
|
| Estrogen Receptor Antagonists | 1 | 2016 | 3 | 0.030 |
Why?
|
| Estrenes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 43 | 0.030 |
Why?
|
| Norpregnadienes | 1 | 2016 | 3 | 0.030 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2016 | 6 | 0.030 |
Why?
|
| Tea | 1 | 2016 | 17 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2016 | 17 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2016 | 19 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 2016 | 20 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2016 | 21 | 0.030 |
Why?
|
| Mifepristone | 1 | 2016 | 81 | 0.030 |
Why?
|
| Uterine Myomectomy | 1 | 2016 | 13 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 1057 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 51 | 0.030 |
Why?
|
| Oximes | 1 | 2016 | 56 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 122 | 0.030 |
Why?
|
| Curcumin | 1 | 2016 | 40 | 0.030 |
Why?
|
| Vitamins | 1 | 2016 | 110 | 0.030 |
Why?
|
| Graft Survival | 1 | 2017 | 461 | 0.030 |
Why?
|
| HELLP Syndrome | 1 | 2014 | 12 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1480 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 11007 | 0.030 |
Why?
|
| Fetal Monitoring | 1 | 2014 | 59 | 0.030 |
Why?
|
| Vitamin D | 1 | 2016 | 193 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 460 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 399 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 315 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 677 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 643 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 226 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2017 | 868 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 414 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13308 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3037 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2593 | 0.010 |
Why?
|